NIH-funded research NIH-funded research

Investigating the effects of metformin and automated insulin delivery on kidney and heart health in youth with Type 1 Diabetes

Official title: MANATEE-T1D: Metformin ANd AutomaTEd insulin delivery system Effects on renal vascular resistance, insulin sensitivity, and cardiometabolic function in youth with Type 1 Diabetes

Funded at Seattle Children's Hospital · NIH-11210200 · Data updated 2026-11-12

This study is looking at whether taking metformin along with an automated insulin delivery system can help improve kidney and heart health in young people aged 12-21 with Type 1 Diabetes.

More Diabetes research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 1, 2021
Project endJuly 31, 2026
Funding year2024
Award (this year)$182,477
NIH project number7K23HL159292-05
Project IDNIH-11210200 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are youth aged 12-21 years with Type 1 Diabetes who are using automated insulin delivery systems.

Less likely to help

Patients who are not using automated insulin delivery systems or are outside the age range may not benefit from this research.

What this research studies

This research explores how metformin, a medication commonly used for diabetes, combined with automated insulin delivery systems, can improve kidney function and heart health in young people with Type 1 Diabetes. The study involves a randomized trial where participants aged 12-21 will receive either metformin or a placebo while using an automated insulin delivery system. Researchers will measure changes in insulin sensitivity and renal vascular resistance to understand the potential benefits of this combined approach. The goal is to find effective strategies to reduce the risk of kidney and cardiovascular diseases in youth with diabetes.

Why it matters

Potential benefit: If successful, this research could lead to improved kidney and heart health outcomes for young people with Type 1 Diabetes.

How similar studies have gone: Previous research has shown that metformin can improve insulin sensitivity in youth with Type 1 Diabetes, but the combination with automated insulin delivery systems is a novel approach.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Tommerdahl, Kalie L — Seattle Children's Hospital
  • Study coordinator: Tommerdahl, Kalie L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.